Examination of Occupational Justice, Activity Performance and Quality of Life in Homeless People

January 10, 2025 updated by: Sumeyye Sarısahin, Bezmialem Vakif University
This concerns the participation of individuals experiencing homelessness, as a disadvantaged group, in meaningful and purposeful occupations, evaluated within the framework of occupational justice. Homeless individuals face numerous social and economic barriers that impact their full participation in societal occupations. However, since survival becomes the primary goal for homeless individuals, meaningful occupations often revolve around surviving on the streets. The aim is to identify problems and constraints to participation in daily life activities so that their participation can be enhanced.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

"The data collection tools will be implemented during face-to-face interviews with participants. Interview durations will vary between 45 to 90 minutes. Interviews with individuals who accept the invitation to participate will be conducted in public places such as cafes, parks, and other community areas in the Beyoğlu district. The data collection process, initiated after ethical approval, will be concluded upon reaching a sufficient number of participants. Homeless individuals contacted through the 'Çorbada Tuzun Olsun Derneği' will be informed about the research and invited to participate. Individuals with neurological or psychiatric conditions that hinder communication and collaboration will not be included in the study. Fourteen homeless individuals aged 18 or older, literate, able to communicate and collaborate, and currently living on the European side of Istanbul will be included in the study. Data collection instruments for the study include a Demographic Information Form, Semi-Structured Interview Guide, Canadian Occupational Performance Measure, Occupational Justice Health Questionnaire, World Health Organization Quality of Life Scale Short Form, and Occupational Balance Questionnaire."

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
14

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey
        • Bezmialem Vakıf Universitesi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Homeless individuals

Description

Inclusion Criteria:

  • Fourteen homeless individuals aged 18 or older, literate, able to communicate and collaborate, and currently living on the European side of Istanbul will be included in the study.

Exclusion Criteria:

  • Individuals with neurological or psychiatric conditions that hinder communication and collaboration will not be included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Demographic Information Form
Time Frame: Temel
Measures Demographic Information. It is a form that includes qualitative questions and checklists to assess individuals' current status regarding demographic data such as age, gender, education level, etc.
Temel
Semi-Structured Interview Guide
Time Frame: Temel
Measures living conditions. It includes 4 open-ended questions.
Temel
Canadian Occupational Performance Measure
Time Frame: Temel
Measures Occupational Performance. Self-care, productivity, and leisure constitute three sections. In the initial stage of evaluation, daily life activities identified by the individual are assessed in order of importance on a scale of 1 to 10 (1: not important at all, 10: very important). In the next stage, the individual selects the five most important activities for themselves and is asked to determine performance and satisfaction scores for each activity using a Likert scale from 1 to 10 (1: very poor performance / very dissatisfied, 10: very good performance / very satisfied). The obtained performance and satisfaction scores are summed and divided by the number of activities identified as important by the individual to obtain the performance and satisfaction scores.
Temel
Occupational Justice Health Survey
Time Frame: Temel
Measures Occupational Justice. It is a five-section assessment tool comprising a total of 27 items, addressing fundamental needs, social, physical, and mental well-being, standards of living, and specific injustices that reduce occupational engagement.
Temel
World Health Organization Quality of Life Scale Short Form
Time Frame: Temel
Measures Quality of Life. Since each domain independently represents the quality of life in its own area, domain scores are calculated between 4 and 20. As scores increase, life quality improves.
Temel

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Bezmialem Vakif University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Sümeyye Sarışahin, MSc, Bezmialem Vakıf Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
July 1, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
November 1, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 20, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 4, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 4, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 11, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 10, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • BEZMİALEM-SARIŞAHİN-2024-0001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings